Order Article Reprints

Sirico M, Bernocchi O, Sobhani N, Giudici F, Corona SP, Vernieri C, Nichetti F, Cappelletti MR, Milani M, Strina C, et al. Early Changes of the Standardized Uptake Values (SUV_max) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer. Cancers. 2020; 12(11):3314. https://doi.org/10.3390/cancers12113314

Sirico, Marianna, Ottavia Bernocchi, Navid Sobhani, Fabiola Giudici, Silvia P. Corona, Claudio Vernieri, Federico Nichetti, Maria Rosa Cappelletti, Manuela Milani, Carla Strina, and et al. 2020. "Early Changes of the Standardized Uptake Values (SUV_max) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer" Cancers 12, no. 11: 3314. https://doi.org/10.3390/cancers12113314

Sirico, M., Bernocchi, O., Sobhani, N., Giudici, F., Corona, S. P., Vernieri, C., Nichetti, F., Cappelletti, M. R., Milani, M., Strina, C., Cervoni, V., Barbieri, G., Ziglioli, N., Dester, M., Bianchi, G. V., De Braud, F., & Generali, D. (2020). Early Changes of the Standardized Uptake Values (SUV_max) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer. Cancers, 12(11), 3314. https://doi.org/10.3390/cancers12113314